These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 21700361

  • 1. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry.
    Leiter U, Buettner PG, Eigentler TK, Bröcker EB, Voit C, Gollnick H, Marsch W, Wollina U, Meier F, Garbe C.
    J Am Acad Dermatol; 2012 Jan; 66(1):37-45. PubMed ID: 21700361
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB, Lee RJ, Prescott RJ, Doherty VR.
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [Abstract] [Full Text] [Related]

  • 5. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
    Meyers MO, Yeh JJ, Frank J, Long P, Deal AM, Amos KD, Ollila DW.
    Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U, Buettner PG, Eigentler TK, Garbe C.
    J Clin Oncol; 2004 Sep 15; 22(18):3660-7. PubMed ID: 15302905
    [Abstract] [Full Text] [Related]

  • 7. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
    Finley JW, Gibbs JF, Rodriguez LM, Letourneau R, Driscoll D, Kraybill W.
    Am Surg; 2000 Jun 15; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
    [Abstract] [Full Text] [Related]

  • 8. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma.
    Turner RM, Bell KJ, Morton RL, Hayen A, Francken AB, Howard K, Armstrong B, Thompson JF, Irwig L.
    J Clin Oncol; 2011 Dec 10; 29(35):4641-6. PubMed ID: 22067399
    [Abstract] [Full Text] [Related]

  • 9. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V, Breuninger H, Garbe C, Moehrle M.
    Br J Dermatol; 2006 Feb 10; 154(2):310-8. PubMed ID: 16433802
    [Abstract] [Full Text] [Related]

  • 10. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
    Eriksson H, Lyth J, Månsson-Brahme E, Frohm-Nilsson M, Ingvar C, Lindholm C, Naredi P, Stierner U, Wagenius G, Carstensen J, Hansson J.
    Eur J Cancer; 2013 Aug 10; 49(12):2705-16. PubMed ID: 23583439
    [Abstract] [Full Text] [Related]

  • 11. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
    Moore Dalal K, Zhou Q, Panageas KS, Brady MS, Jaques DP, Coit DG.
    Ann Surg Oncol; 2008 Aug 10; 15(8):2206-14. PubMed ID: 18512102
    [Abstract] [Full Text] [Related]

  • 12. Follow-up schedules after treatment for malignant melanoma.
    Francken AB, Accortt NA, Shaw HM, Colman MH, Wiener M, Soong SJ, Hoekstra HJ, Thompson JF.
    Br J Surg; 2008 Nov 10; 95(11):1401-7. PubMed ID: 18844268
    [Abstract] [Full Text] [Related]

  • 13. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.
    Br J Dermatol; 2008 Sep 10; 159(3):597-605. PubMed ID: 18616789
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG, Leiter U, Eigentler TK, Garbe C.
    Cancer; 2005 Feb 01; 103(3):616-24. PubMed ID: 15630700
    [Abstract] [Full Text] [Related]

  • 16. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
    Bedikian AY, Wei C, Detry M, Kim KB, Papadopoulos NE, Hwu WJ, Homsi J, Davies M, McIntyre S, Hwu P.
    Am J Clin Oncol; 2011 Dec 01; 34(6):603-10. PubMed ID: 21150567
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A, Wanek LA, Morton DL.
    J Am Coll Surg; 1995 Sep 01; 181(3):193-201. PubMed ID: 7670677
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study.
    Cohn-Cedermark G, Månsson-Brahme E, Rutqvist LE, Larsson O, Singnomklao T, Ringborg U.
    Cancer; 1997 Oct 15; 80(8):1418-25. PubMed ID: 9338465
    [Abstract] [Full Text] [Related]

  • 19. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma.
    Posther KE, Selim MA, Mosca PJ, Stanley WE, Johnson JL, Tyler DS, Seigler HF.
    Ann Surg Oncol; 2006 May 15; 13(5):728-39. PubMed ID: 16538415
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.